Muscarinic Acetylcholine Receptor Market - Global Outlook and Forecast 2022-2028

January 2022 | 65 pages | ID: M57F85C08CFEEN
Market Monitor Global

Abstracts

Muscarinic Acetylcholine Receptor (m-g protein coupled Receptor) is an autoantibody in the serum of patients with myasthenia gravis.

This report contains market size and forecasts of Muscarinic Acetylcholine Receptor in Global, including the following market information:

Global Muscarinic Acetylcholine Receptor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Muscarinic Acetylcholine Receptor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

M1 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Muscarinic Acetylcholine Receptor include Anavex Life Sciences Corp, AstraZeneca Plc, Heptares Therapeutics Ltd, Karuna Pharmaceuticals Inc, NeuroHealing Pharmaceuticals Inc and Sumitomo Dainippon Pharma Co Ltd, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Muscarinic Acetylcholine Receptor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Muscarinic Acetylcholine Receptor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Muscarinic Acetylcholine Receptor Market Segment Percentages, by Type, 2021 (%)

• M1
• M4
• M5
• Others

Global Muscarinic Acetylcholine Receptor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Muscarinic Acetylcholine Receptor Market Segment Percentages, by Application, 2021 (%)

• Attention Deficit Hyperactivity Disorder
• Psychiatric Disorders
• Alzheimer's Disease
• Chronic Obstructive Pulmonary Disease
• Memory Impairment

Global Muscarinic Acetylcholine Receptor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Muscarinic Acetylcholine Receptor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Muscarinic Acetylcholine Receptor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Muscarinic Acetylcholine Receptor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Anavex Life Sciences Corp
• AstraZeneca Plc
• Heptares Therapeutics Ltd
• Karuna Pharmaceuticals Inc
• NeuroHealing Pharmaceuticals Inc
• Sumitomo Dainippon Pharma Co Ltd

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Muscarinic Acetylcholine Receptor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Muscarinic Acetylcholine Receptor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MUSCARINIC ACETYLCHOLINE RECEPTOR OVERALL MARKET SIZE

2.1 Global Muscarinic Acetylcholine Receptor Market Size: 2021 VS 2028
2.2 Global Muscarinic Acetylcholine Receptor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Muscarinic Acetylcholine Receptor Players in Global Market
3.2 Top Global Muscarinic Acetylcholine Receptor Companies Ranked by Revenue
3.3 Global Muscarinic Acetylcholine Receptor Revenue by Companies
3.4 Top 3 and Top 5 Muscarinic Acetylcholine Receptor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Muscarinic Acetylcholine Receptor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Muscarinic Acetylcholine Receptor Players in Global Market
  3.6.1 List of Global Tier 1 Muscarinic Acetylcholine Receptor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Muscarinic Acetylcholine Receptor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Muscarinic Acetylcholine Receptor Market Size Markets, 2021 & 2028
  4.1.2 M1
  4.1.3 M4
  4.1.4 M5
  4.1.5 Others
4.2 By Type - Global Muscarinic Acetylcholine Receptor Revenue & Forecasts
  4.2.1 By Type - Global Muscarinic Acetylcholine Receptor Revenue, 2017-2022
  4.2.2 By Type - Global Muscarinic Acetylcholine Receptor Revenue, 2023-2028
  4.2.3 By Type - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Muscarinic Acetylcholine Receptor Market Size, 2021 & 2028
  5.1.2 Attention Deficit Hyperactivity Disorder
  5.1.3 Psychiatric Disorders
  5.1.4 Alzheimer's Disease
  5.1.5 Chronic Obstructive Pulmonary Disease
  5.1.6 Memory Impairment
5.2 By Application - Global Muscarinic Acetylcholine Receptor Revenue & Forecasts
  5.2.1 By Application - Global Muscarinic Acetylcholine Receptor Revenue, 2017-2022
  5.2.2 By Application - Global Muscarinic Acetylcholine Receptor Revenue, 2023-2028
  5.2.3 By Application - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Muscarinic Acetylcholine Receptor Market Size, 2021 & 2028
6.2 By Region - Global Muscarinic Acetylcholine Receptor Revenue & Forecasts
  6.2.1 By Region - Global Muscarinic Acetylcholine Receptor Revenue, 2017-2022
  6.2.2 By Region - Global Muscarinic Acetylcholine Receptor Revenue, 2023-2028
  6.2.3 By Region - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Muscarinic Acetylcholine Receptor Revenue, 2017-2028
  6.3.2 US Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.3.3 Canada Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.3.4 Mexico Muscarinic Acetylcholine Receptor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Muscarinic Acetylcholine Receptor Revenue, 2017-2028
  6.4.2 Germany Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.3 France Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.4 U.K. Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.5 Italy Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.6 Russia Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.7 Nordic Countries Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.4.8 Benelux Muscarinic Acetylcholine Receptor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Muscarinic Acetylcholine Receptor Revenue, 2017-2028
  6.5.2 China Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.5.3 Japan Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.5.4 South Korea Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.5.5 Southeast Asia Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.5.6 India Muscarinic Acetylcholine Receptor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Muscarinic Acetylcholine Receptor Revenue, 2017-2028
  6.6.2 Brazil Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.6.3 Argentina Muscarinic Acetylcholine Receptor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Muscarinic Acetylcholine Receptor Revenue, 2017-2028
  6.7.2 Turkey Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.7.3 Israel Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.7.4 Saudi Arabia Muscarinic Acetylcholine Receptor Market Size, 2017-2028
  6.7.5 UAE Muscarinic Acetylcholine Receptor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Anavex Life Sciences Corp
  7.1.1 Anavex Life Sciences Corp Corporate Summary
  7.1.2 Anavex Life Sciences Corp Business Overview
  7.1.3 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Major Product Offerings
  7.1.4 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.1.5 Anavex Life Sciences Corp Key News
7.2 AstraZeneca Plc
  7.2.1 AstraZeneca Plc Corporate Summary
  7.2.2 AstraZeneca Plc Business Overview
  7.2.3 AstraZeneca Plc Muscarinic Acetylcholine Receptor Major Product Offerings
  7.2.4 AstraZeneca Plc Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Plc Key News
7.3 Heptares Therapeutics Ltd
  7.3.1 Heptares Therapeutics Ltd Corporate Summary
  7.3.2 Heptares Therapeutics Ltd Business Overview
  7.3.3 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Major Product Offerings
  7.3.4 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.3.5 Heptares Therapeutics Ltd Key News
7.4 Karuna Pharmaceuticals Inc
  7.4.1 Karuna Pharmaceuticals Inc Corporate Summary
  7.4.2 Karuna Pharmaceuticals Inc Business Overview
  7.4.3 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Major Product Offerings
  7.4.4 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.4.5 Karuna Pharmaceuticals Inc Key News
7.5 NeuroHealing Pharmaceuticals Inc
  7.5.1 NeuroHealing Pharmaceuticals Inc Corporate Summary
  7.5.2 NeuroHealing Pharmaceuticals Inc Business Overview
  7.5.3 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Major Product Offerings
  7.5.4 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.5.5 NeuroHealing Pharmaceuticals Inc Key News
7.6 Sumitomo Dainippon Pharma Co Ltd
  7.6.1 Sumitomo Dainippon Pharma Co Ltd Corporate Summary
  7.6.2 Sumitomo Dainippon Pharma Co Ltd Business Overview
  7.6.3 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Major Product Offerings
  7.6.4 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Revenue in Global Market (2017-2022)
  7.6.5 Sumitomo Dainippon Pharma Co Ltd Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Muscarinic Acetylcholine Receptor Market Opportunities & Trends in Global Market
Table 2. Muscarinic Acetylcholine Receptor Market Drivers in Global Market
Table 3. Muscarinic Acetylcholine Receptor Market Restraints in Global Market
Table 4. Key Players of Muscarinic Acetylcholine Receptor in Global Market
Table 5. Top Muscarinic Acetylcholine Receptor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Muscarinic Acetylcholine Receptor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Muscarinic Acetylcholine Receptor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Muscarinic Acetylcholine Receptor Product Type
Table 9. List of Global Tier 1 Muscarinic Acetylcholine Receptor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Muscarinic Acetylcholine Receptor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Muscarinic Acetylcholine Receptor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Muscarinic Acetylcholine Receptor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Muscarinic Acetylcholine Receptor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Muscarinic Acetylcholine Receptor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Muscarinic Acetylcholine Receptor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Muscarinic Acetylcholine Receptor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2023-2028
Table 30. Anavex Life Sciences Corp Corporate Summary
Table 31. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product Offerings
Table 32. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Plc Corporate Summary
Table 34. AstraZeneca Plc Muscarinic Acetylcholine Receptor Product Offerings
Table 35. AstraZeneca Plc Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)
Table 36. Heptares Therapeutics Ltd Corporate Summary
Table 37. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product Offerings
Table 38. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)
Table 39. Karuna Pharmaceuticals Inc Corporate Summary
Table 40. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offerings
Table 41. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)
Table 42. NeuroHealing Pharmaceuticals Inc Corporate Summary
Table 43. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product Offerings
Table 44. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)
Table 45. Sumitomo Dainippon Pharma Co Ltd Corporate Summary
Table 46. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product Offerings
Table 47. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Muscarinic Acetylcholine Receptor Segment by Type in 2021
Figure 2. Muscarinic Acetylcholine Receptor Segment by Application in 2021
Figure 3. Global Muscarinic Acetylcholine Receptor Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Muscarinic Acetylcholine Receptor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Muscarinic Acetylcholine Receptor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Muscarinic Acetylcholine Receptor Revenue in 2021
Figure 8. By Type - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 12. US Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 16. Germany Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 17. France Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 24. China Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 28. India Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 30. Brazil Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Muscarinic Acetylcholine Receptor Revenue Market Share, 2017-2028
Figure 33. Turkey Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Muscarinic Acetylcholine Receptor Revenue, (US$, Mn), 2017-2028
Figure 37. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Plc Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)